1. Mulitple sclerosis and allied demyelinative diseases. In Adams and Victor’s Principles of Neurology. Edited by Victor M, Ropper AH, Adams RD. New York: McGraw-Hill; 2001.
2. Matthews B: Differential diagnosis of multiple sclerosis and related disorders. In Multiple Sclerosis. Edited by McAlpines ER. Cambridge: Churchill Livingstone; 1998.
3. Lucchinetti C, Bruck W, Parisi J, et al.: Heterogeneity of multiple sclerosis lesions: implications for the pathogenesis of demyelination. Ann Neurol 2000, 47:707–717. The authors provided a very detailed description of the different lesion pathologies in autopsy and biopsy studies from multiple sclerosis patients.
4. Filippi M, Yousry T, Campi A, et al.: Comparison of triple dose versus standard dose gadolinium-DTPA for detection of MRI enhancing lesions in patients with MS. Neurology 1996, 46:379–384.
5. Waesberge JH, van Walderveen MA, Castelijns JA, et al.: Patterns of lesions development in multiple sclerosis: longitudinal observations with T1-weighted spin-echo and magnetization transfer MR. Am J Neuradiol 1998, 19:675–683.